State Street’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27M | Buy |
4,658,174
+541,250
| +13% | +$3.59M | ﹤0.01% | 2080 |
|
|
2025
Q4 | $32.3M | Buy |
4,116,924
+378,595
| +10% | +$2.98M | ﹤0.01% | 1994 |
|
|
2025
Q3 | $30.4M | Sell |
3,738,329
-44,871
| -1% | -$298K | ﹤0.01% | 2005 |
|
|
2025
Q2 | $17.7M | Buy |
3,783,200
+457,945
| +14% | +$2.1M | ﹤0.01% | 2253 |
|
|
2025
Q1 | $18.3M | Sell |
3,325,255
-16,619
| -0.5% | -$67.1K | ﹤0.01% | 2187 |
|
|
2024
Q4 | $11.3M | Buy |
3,341,874
+137,156
| +4% | +$441K | ﹤0.01% | 2553 |
|
|
2024
Q3 | $9.13M | Sell |
3,204,718
-53,915
| -2% | -$138K | ﹤0.01% | 2664 |
|
|
2024
Q2 | $7.33M | Buy |
3,258,633
+43,617
| +1% | +$87.9K | ﹤0.01% | 2746 |
|
|
2024
Q1 | $7.11M | Buy |
3,215,016
+490,890
| +18% | +$1.27M | ﹤0.01% | 2765 |
|
|
2023
Q4 | $6.4M | Buy |
2,724,126
+154,004
| +6% | +$284K | ﹤0.01% | 2830 |
|
|
2023
Q3 | $4.78M | Buy |
2,570,122
+25,224
| +1% | +$57.8K | ﹤0.01% | 2940 |
|
|
2023
Q2 | $6.67M | Buy |
2,544,898
+261,327
| +11% | +$665K | ﹤0.01% | 2856 |
|
|
2023
Q1 | $3.72M | Buy |
2,283,571
+138,341
| +6% | +$173K | ﹤0.01% | 3105 |
|
|
2022
Q4 | $2.85M | Sell |
2,145,230
-29,013
| -1% | -$41K | ﹤0.01% | 3267 |
|
|
2022
Q3 | $3.39M | Buy |
2,174,243
+53,508
| +3% | +$88.5K | ﹤0.01% | 3250 |
|
|
2022
Q2 | $3.27M | Buy |
2,120,735
+1,735,974
| +451% | +$3.66M | ﹤0.01% | 3302 |
|
|
2022
Q1 | $985K | Buy |
384,761
+18,252
| +5% | +$44.6K | ﹤0.01% | 3820 |
|
|
2021
Q4 | $1.07M | Buy |
366,509
+149,627
| +69% | +$323K | ﹤0.01% | 3800 |
|
|
2021
Q3 | $531K | Buy |
216,882
+2,200
| +1% | +$6.39K | ﹤0.01% | 3952 |
|
|
2021
Q2 | $874K | Sell |
214,682
-569,857
| -73% | -$2.17M | ﹤0.01% | 3690 |
|
|
2021
Q1 | $3.54M | Buy |
784,539
+16,460
| +2% | +$88.8K | ﹤0.01% | 3196 |
|
|
2020
Q4 | $3.78M | Buy |
768,079
+92,520
| +14% | +$463K | ﹤0.01% | 3106 |
|
|
2020
Q3 | $4.01M | Buy |
675,559
+56,161
| +9% | +$225K | ﹤0.01% | 2889 |
|
|
2020
Q2 | $1.65M | Buy |
619,398
+77,367
| +14% | +$269K | ﹤0.01% | 3256 |
|
|
2020
Q1 | $1.06M | Buy |
542,031
+41,630
| +8% | +$179K | ﹤0.01% | 3292 |
|
|
2019
Q4 | $3.53M | Buy |
500,401
+33,950
| +7% | +$280K | ﹤0.01% | 3016 |
|
|
2019
Q3 | $4.58M | Buy |
466,451
+67,820
| +17% | +$762K | ﹤0.01% | 2825 |
|
|
2019
Q2 | $4.56M | Buy |
398,631
+183,285
| +85% | +$1.92M | ﹤0.01% | 2876 |
|
|
2019
Q1 | $2.16M | Buy |
215,346
+116,632
| +118% | +$1.49M | ﹤0.01% | 3123 |
|
|
2018
Q4 | $1.68M | Buy |
98,714
+35,789
| +57% | +$718K | ﹤0.01% | 3182 |
|
|
2018
Q3 | $1.11M | Buy |
+62,925
| New | +$1.37M | ﹤0.01% | 3388 |
|
Other funds holding XERS
VCM
RA
N
VPM
